Nasal Mask and Prong Use in Non-invasive Ventilation for Newborns

NCT ID: NCT01989442

Last Updated: 2015-01-15

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

100 participants

Study Classification

INTERVENTIONAL

Study Start Date

2013-11-30

Study Completion Date

2015-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The study aims to investigate efficacy and safety of nasal mask and prongs used in non-invasive ventilation in newborns by using esophageal pressure transducer.

The parameters including ventilation duration, hospitalization duration, pulmonary outcomes and side effects will be evaluated.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Although it seems as more non-invasive there is still lack of data especially on efficacy of nasal mask use in NIV for newborns. By using esophageal pressure transducers we will evaluate the pressure supplied by the ventilation mode and compare it with more commonly used nasal prongs. The investigators will test the hypothesis of equivalence of nasal mask in comparison to prongs with better safety parameters.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Bronchopulmonary Dysplasia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Nasal Mask

patients who receive NIV by nasal mask interface after randomization

Group Type EXPERIMENTAL

nasal mask

Intervention Type DEVICE

patients randomized to nasal mask for NIV will use nasal mask as an interface during continuous positive airway pressure support

nasal prong

patients who receive NIV by nasal prongs as interface after randomization

Group Type ACTIVE_COMPARATOR

binasal prongs

Intervention Type DEVICE

patients randomized to binasal prongs for NIV will use binasal prongs as an interface during continuous positive airway pressure support

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

binasal prongs

patients randomized to binasal prongs for NIV will use binasal prongs as an interface during continuous positive airway pressure support

Intervention Type DEVICE

nasal mask

patients randomized to nasal mask for NIV will use nasal mask as an interface during continuous positive airway pressure support

Intervention Type DEVICE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

viasys healthcare infant flow system- binasal prongs viasys healthcare infant flow system-nasal mask

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* all newborns who require NIV as first line treatment as respiratory support in delivery room or neonatal intensive care unit

Exclusion Criteria

* who are intubated in delivery room or neonatal intensive care unit before randomization
* with congenital anomaly
* patients who require NIV more than 3 days
Maximum Eligible Age

28 Days

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Ankara University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Ufuk Cakir

MD

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Saadet ARSAN, Professor

Role: PRINCIPAL_INVESTIGATOR

Ankara University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Ankara University

Ankara, Ankara, Turkey (Türkiye)

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Turkey (Türkiye)

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Ankara University

Role: CONTACT

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Ufuk Cakir

Role: primary

905058581781

References

Explore related publications, articles, or registry entries linked to this study.

McCarthy LK, Twomey AR, Molloy EJ, Murphy JF, O'Donnell CP. A randomized trial of nasal prong or face mask for respiratory support for preterm newborns. Pediatrics. 2013 Aug;132(2):e389-95. doi: 10.1542/peds.2013-0446. Epub 2013 Jul 29.

Reference Type BACKGROUND
PMID: 23897911 (View on PubMed)

Kieran EA, Twomey AR, Molloy EJ, Murphy JF, O'Donnell CP. Randomized trial of prongs or mask for nasal continuous positive airway pressure in preterm infants. Pediatrics. 2012 Nov;130(5):e1170-6. doi: 10.1542/peds.2011-3548. Epub 2012 Oct 22.

Reference Type BACKGROUND
PMID: 23090339 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Map-NIV Trial

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.